Brief: Pulmatrix Reports Qtrly Loss Per Share $0.23

Pulmatrix

14/05/2020 14:27

May 14 (Reuters) - Pulmatrix Inc  PULM.O :
    * PULMATRIX REPORTS Q1 2020 RESULTS
    * Q1 REVENUE $2.8 MILLION
    * PULMATRIX - CURRENTLY PLAN TO INITIATE PUR1800 PH1B
CLINICAL
STUDY AND CHRONIC TOXICOLOGY STUDIES IN SECOND HALF OF 2020
    * PULMATRIX - ENROLLMENT IN PHASE 2B CLINICAL STUDY OF
PULMAZOLE
FOR TREATMENT OF ABPA HAS BEEN TEMPORARILY PAUSED
    * PULMATRIX - QTRLY LOSS PER SHARE $0.23

Source text for Eikon:  ID:nPnbw85PYa 
Further company coverage:  PULM.O 

 ((Reuters.Briefs@thomsonreuters.com;))